IN DATA Powered by Inside the deal Deals analysis Rankings Economic data Macro-economic indicators INSIDE THE DEAL AstraZeneca and Fusion team up on targeted alpha therapies Fusion and AstraZeneca are partnering to develop next-generation cancer treatments Deals Analysis North America deals volume up 4% YoY North America is leading in terms of deal value, but recorded the lowest YoY growth in deals volume at 4% Rankings Who's leading Japan's R&D expenditure? Our pharma industry key list brings you the 15 leading companies in Japan by R&D expenditure Inside the deal Deals analysis Rankings Economic data Macro-economic indicators 02/24/2024 10:38:19
Inside the deal
Deals analysis
Rankings
Economic data
Macro-economic indicators